Home/Filings/4/0001127602-20-030401
4//SEC Filing

Toth Christopher A. 4

Accession 0001127602-20-030401

CIK 0000203527other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 3:19 PM ET

Size

31.0 KB

Accession

0001127602-20-030401

Insider Transaction Report

Form 4
Period: 2020-12-01
Toth Christopher A.
SVP and Pres. Oncology Systems
Transactions
  • Tax Payment

    Common Stock

    2020-12-01$174.19/sh7,232$1,259,7425,742 total
  • Exercise/Conversion

    Non Qualified Stock Option (Right to Buy)

    2020-12-014,8230 total
    Exercise: $80.40Exp: 2024-02-10Common Stock (4,823 underlying)
  • Exercise/Conversion

    Non Qualified Stock Option (Right to Buy)

    2020-12-0113,4500 total
    Exercise: $146.91Exp: 2027-02-13Common Stock (13,450 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-01$80.40/sh+4,823$387,7697,694 total
  • Exercise/Conversion

    Common Stock

    2020-12-01$146.91/sh+13,450$1,975,94020,244 total
  • Exercise/Conversion

    Non Qualified Stock Option (Right to Buy)

    2020-12-018,5730 total
    Exercise: $131.77Exp: 2026-02-14Common Stock (8,573 underlying)
  • Tax Payment

    Common Stock

    2020-12-01$174.19/sh3,514$612,1044,180 total
  • Exercise/Conversion

    Common Stock

    2020-12-01$131.77/sh+8,573$1,129,66414,315 total
  • Tax Payment

    Common Stock

    2020-12-01$174.19/sh12,388$2,157,8667,856 total
  • Exercise/Conversion

    Non Qualified Stock Option (Right to Buy)

    2020-12-018,7940 total
    Exercise: $112.82Exp: 2025-02-08Common Stock (8,794 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2020-12-0111,5944,825 total
    Common Stock (11,594 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-01$112.82/sh+8,794$992,13912,974 total
  • Tax Payment

    Common Stock

    2020-12-01$174.19/sh7,521$1,310,0836,794 total
  • Exercise/Conversion

    Common Stock

    2020-12-01+11,59419,450 total
  • Tax Payment

    Common Stock

    2020-12-01$174.19/sh5,748$1,001,24413,702 total
Footnotes (11)
  • [F1]Represents shares withheld for payment of exercise price of $80.40 per share as well as payment of federal, state and payroll taxes due on settlement
  • [F10]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
  • [F11]Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units vest originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023.
  • [F2]Represents shares withheld for payment of exercise price of $112.82 per share as well as payment of federal, state and payroll taxes due on settlement.
  • [F3]Represents shares withheld for payment of exercise price of $131.77 per share as well as payment of federal, state and payroll taxes due on settlement
  • [F4]Represents shares withheld for payment of exercise price of $146.91 per share as well as payment of federal, state and payroll taxes due on settlement
  • [F5]Represents shares withheld from vested RSUs for the payment of federal, state and payroll taxes due on settlement.
  • [F6]Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
  • [F7]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
  • [F8]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
  • [F9]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 13, 2021, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Issuer

VARIAN MEDICAL SYSTEMS INC

CIK 0000203527

Entity typeother

Related Parties

1
  • filerCIK 0001753950

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 3:19 PM ET
Size
31.0 KB